JP Morgan Chase
HURA

JP Morgan Chase’s TuHURA Biosciences HURA Stock Holding History

JP Morgan Chase’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481 Sell
210
-17,494
-99% -$40.8K ﹤0.01% 7423
2026
Q1 		$30.6K Buy
17,704
+4,157
+31% +$5.09K ﹤0.01% 6385
2025
Q4 		$10.3K Buy
13,547
+3,183
+31% +$6.09K ﹤0.01% 6671
2025
Q3 		$25.7K Sell
10,364
-1,774
-15% -$4.67K ﹤0.01% 6414
2025
Q2 		$27.1K Buy
+12,138
New +$41K ﹤0.01% 6099
2023
Q3 		– Sell
-16
Closed -$2.25K – 7779
2023
Q2 		$2.25K Buy
+16
New +$1.82K ﹤0.01% 6317

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase's HURA Position: Q2 2026 in Review

JP Morgan Chase reduced its TuHURA Biosciences (HURA) stake by 99% in Q2 2026, selling an estimated $40.8K and leaving 210 shares worth $481. The position accounts for ﹤0.01% of the portfolio, ranked #7423.

JP Morgan Chase first reported a position in HURA in Q2 2023 and has held it in 6 quarters since. The position peaked at $30.6K in Q1 2026. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • JP Morgan Chase held 210 shares of TuHURA Biosciences worth $481 as of Q2 2026.
  • JP Morgan Chase sold 17,494 TuHURA Biosciences shares in Q2 2026, an estimated $40.8K.
  • TuHURA Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7423 holding.
  • JP Morgan Chase first reported a position in TuHURA Biosciences in Q2 2023 and has held it in 6 quarters since.
  • JP Morgan Chase's TuHURA Biosciences position peaked at $30.6K in Q1 2026.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.